Hensel Davest Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Hensel Davest Indonesia Tbk. trades at Rp50 (market cap 76.23B, 3.54M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.2× Hensel Davest Indonesia Tbk.'s market cap, and Hensel Davest Indonesia Tbk. is more actively traded (3.54M versus 71K). Which is the better fit depends on your goals.
| HDIT | OBAT | |
|---|---|---|
Market Cap | 76.23B | 167.37B |
Volume | 3.54M | 71K |
Lot | 35.39K | 710 |
Turnover | 176.96M | 17.51M |
Average Price | 50 | 246.63 |
Value | 176.96M | 17.51M |
Indicative Equilibrium Price | 50 | 246 |
Indicative Equilibrium Volume | 1 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Read more on HDIT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →